Skip to main content
SpringerLink
Log in

The reality of psychomotor problems, and the possibility of Parkinson’s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)

  • Reply
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Cohen RS (1995) Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans. Progr Neuropsychopharmacol Biol Psychiatry 19:1137–1145

    Article  CAS  Google Scholar 

  • Commins DL, Vosmer G, Virus R, Wolverton W, Seiden L (1987) Biochemical and histological evidence that 3,4-methylenedioxymethamphetamine is toxic to neurones in the rat brain. J Pharmacol Exp Ther 241:338–345

    CAS  PubMed  Google Scholar 

  • Ferrucci M, Gesi M, Lenzi P, Soldani P, Ruffoli R, Pellegrini A, Ruggieri S, Paparelli A, Fornai F (2002) Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls. Neurol Sci 23:S75–S76

    PubMed  Google Scholar 

  • Hansen D, Maycock B, Lower T (2001) Weddings, parties, anything: a qualitative analysis of ecstasy use in Perth Australia. Int J Drug Policy 12:181–199

    Article  PubMed  Google Scholar 

  • Jansen KLR (1999) Ecstasy (MDMA) dependence. Drug Alcohol Depend 53:121–124

    CAS  PubMed  Google Scholar 

  • McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) (±) Serotonin neurotoxicity after 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): a controlled study in humans. Neuropsychopharmacology 10:129–138

    CAS  PubMed  Google Scholar 

  • Parrott AC (2001) Human psychopharmacology of ecstasy/MDMA: a review of fifteen years of empirical research. Hum Psychopharmacol 16:557–578

    CAS  Google Scholar 

  • Parrott AC (2002) Tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. Psychobiology Newsletter (Winter 2002), pp 16–17

  • Parrott AC (2003) Chronic tolerance to recreational ecstasy or MDMA: a new underlying mechanism? J Psychopharmacol (in press)

    Google Scholar 

  • Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition; before, during, and after a Saturday night dance. Psychopharmacology 139:261–268

    Article  CAS  PubMed  Google Scholar 

  • Parrott AC, Buchanan T, Scholey AB, Heffernan TM, Ling J, Rodgers J (2002) Ecstasy/MDMA attributed problems reported by novice, moderate and heavy users. Hum Psychopharmacol 17:309–312

    Article  CAS  PubMed  Google Scholar 

  • Parrott AC, Buchanan T, Heffernan TM, Scholey AB, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology (in press)

  • Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273–277

    CAS  PubMed  Google Scholar 

  • Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (“ecstasy”). Science 297:2260–2263

    Article  CAS  PubMed  Google Scholar 

  • Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2003) MDMA (“ecstasy”) and neurotoxicity: response to Mithoefer et al. Science 300:1504–1505

    Article  CAS  PubMed  Google Scholar 

  • Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology 151:19–24

    CAS  PubMed  Google Scholar 

  • Scholey AB, Parrott AC, Buchanan T, Heffernan T, Ling J, Rodgers J (2003) Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: a www study. Addict Behav (in press)

  • Sumnall HR, Jerome L, Doblin R, Mithoefer MC (2003) Response to Parrott AC, Buchanan T, Heffernan TM, Scholey AB, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology (in press)

  • Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55:105–115

    CAS  PubMed  Google Scholar 

  • Winstock AR, Griffiths P, Stewart D (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64:9–17

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Psychology, University of East London, London, E15 4LZ, UK

    A. C. Parrott

  2. Department of Clinical Psychology, University of Newcastle, Newcastle-upon-Tyne, NE1 7RU, UK

    J. Rodgers

  3. Department of Psychology, University of Westminster, London, W1B 2UW, UK

    T. Buchanan

  4. Department of Psychology, Northumbria University, Newcastle-upon-Tyne, NE1 8ST, UK

    A. B. Scholey & T. Heffernan

  5. Psychology Section, University of Teesside, Middlesborough, TS1 3BA, UK

    J. Ling

Authors
  1. A. C. Parrott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Rodgers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Buchanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. B. Scholey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Heffernan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Ling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. C. Parrott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parrott, A.C., Rodgers, J., Buchanan, T. et al. The reality of psychomotor problems, and the possibility of Parkinson’s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003). Psychopharmacology 171, 231–233 (2004). https://doi.org/10.1007/s00213-003-1600-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1600-1

Keywords

Search

Navigation